{"nct_id":"NCT04949256","title":"Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2021-07-28","start_date_type":"ACTUAL","primary_completion_date":"2025-05-08","primary_completion_date_type":"ACTUAL","completion_date":"2027-01-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MRK"]}